Protective and Memory Immunity to Histoplasma capsulatum in the Absence of IL-10

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 5353-5362

  Deepe Jr , George S ^a   Gibbons, Reta S ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; GR 1 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 10; MAC 3 ANTIGEN; MONOCLONAL ANTIBODY; PADGEM PROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; IMMUNITY; IMMUNIZATION; INFLAMMATORY CELL; LUNG; LYMPHOCYTE COUNT; MEMORY CELL; MOUSE; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; SPLEEN CELL; SUPERINFECTION;

EID: 0242494434     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.5353     Document Type: Article

References (41)

1. Deepe, G. S., Jr. 2000. Histoplasma capsulatum. In Principles and Practice of Infectious Diseases, 5th Ed. G. L. Mandell, J. E. Bennett, and R. Dolin, eds. Churchill Livingstone, Philadelphia, pp. 2718-32.
2. Zhou, P., M. C. Sieve, J. Bennett, J. Kwon-Chung, R. P. Tewari, R. T. Gazinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected Histoplasma capsulatum through induction of IFN-γ J. Immunol. 155:785.
3. Allendoerfer, R., G. P. Boivin, and G. S. Deepe, Jr. 1997. Modulation of immune responses in murine pulmonary histoplasmosis. J. Infect. Dis. 175:905.
4. Cain, J A., and G. S. Deepe, Jr. 1998. Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect. Immun. 66:1473.
5. Smith, J. G., D. M. Magee, D. W. Williams, and J. R. Graybill. 1990. Tumor necrosis factor-plays a role in host defense against Histoplasma capsulatum. J. Infect. Dis. 162:1349.
6. Wu-Hsieh, B. A., G.-S. Lee, M. Franco, and F. M. Hofman. 1992. Early activation of splenic macrophages by tumor necrosis factor α is important in determining the outcome of experimental histoplasmosis in mice. Infect. Immun. 60:4230.
7. Allendoerfer, R, and G. S. Deepe, Jr. 1998. Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J. Immunol. 160:6072.
8. Zhou, P., G. Miller, R. A. Seder. 1998. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ J. Immunol. 160:1359.
9. Deepe, G. S., Jr., R. Gibbons, R., and E. Woodward. 1999. Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum. J. Immunol. 163:4985.
10. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683.
11. Cassatella, M. A., L. Meda, S. Bonora, M. Ceska, and G. Constantin. 1993. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178:2207.
12. Roilides, E., H. Katsifa, S. Tsaparidou, T. Stergiopoulou, C. Panteliadis, and T. J. Walsh. 2000. Interleukin-10 suppresses phagocytic and antihyphal activities of human neutrophils. Cytokine 12:379.
13. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K W., and A. O'Garra. 1991. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
14. Ding, L., and E. M. Shevach. 1992. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulation. J. Immunol. 148:3133.
15. Allendörfer-Femandez, R., G. D. Brunner, and G. S. Deepe, Jr. 1999. Complex requirements for nascent and secondary immunity in pulmonary histoplasmosis. J. Immunol. 162:7389.
16. Lauvau, G., S. Vijh, P. Kong, T. Horng, K. Kerksiek, N. Serbina, R. A. Turna, and E. G. Pamer. 2001. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294:1735.
17. Kaech, S. M. E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251.
18. Murray, P. J., and R. A. Young. 1999. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect. Immun. 67:3087.
19. Murphy, M. L., U. Willie, E. N. Villegas, C. A. Hunter, and J. P. Farrell. 2001. IL-10 mediates susceptibility to Leishmania donovani infection. Eur. J. Immunol. 31:2848.
20. Mentink, M. K., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166:1141.
21. Fierer, J., L. Walls, L. Eckmann, T. Yamamoto, and T. N. Kirkland. 1998. Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis. Infect. Immun. 66:4397.
22. Silva, R. A., and R. Appelberg. 2001. Blocking the receptor for interleukin-10 protects mice from lethal listeriosis. Antimicrob. Agents Chemother. 45:1312.
23. Del Sero, G., A. Mencacci, E. Cenci, C. F. d'Ostiani, C. Montagnoli, A. Bacci, P. Mosci, M. Kopf, and L. Romani. 1999. Antifungal type 1 responses are up-regulated in IL-10-deficient mice. Microbes Infect. 14:1169.
24. Vazquez-Torres, A., J. Jones-Carson, and R. D. Wagner, T. Warner, and E. Balish. 1999. Early resistance of interluekin-10 knockout mice to acute systemic candidiasis. Infect. Immun. 67:670.
25. Schopf, L. R., K. F. Hoffman, A. W. Cheever, J. F. Urban, Jr., and T. A. Wynn. 2002. IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. J. Immunol. 168:2383.
26. Li, C., I. Corraliza, and J. Langhorn. 1999. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67:4435.
27. Mencacci, A., E. Cenci, G. Del Sero, C. Fe d'Ostiani, P. Mosci, G. Trinchieri, L. Adorini, and L. Romani. 1998. IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J. Immunol. 161:6228.
28. + T cells and accompanied by overproduction of IL-12, 1FN-γ, and TNF-α. J. Immunol. 157:798.
29. Hunter, C. A., L. A. Ellis-Neyes, T. Slifer, S. Kanaly, G. Grunig, M. Fort, D. Rennick, and F. G. Araujo. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158:3311.
30. + T cells exert protection in murine pulmonary histoplasmosis. J. Clin. Invest. 102:984.
31. de Waal Malefyt, R. C. G. Figdor, and J. E. de Vries. 1993. Effect of interleukin 4 on monocyte functions: comparison to interleukin 13. Res. Immunol. 144:629.
32. Finkelman, F. D., T. Shea-Donohue, J. Goldhill, C. A. Sullivan, S. C. Morris, K. B. Madden, W. C. Gause, and J. F. Urban, Jr. 1997. Cytokine regulation of host defense against parasitic gastrointestinal helminths: lessons from studies with rodents. Annu. Rev. Immunol. 16:495.
33. Bullock, W. E., and S. D. Wright. 1987. Role of the adherence-promoting receptors, CR3, LFA-1, and p150, 95, in binding of Histoplasma capsulatum by human macrophages. J. Exp. Med. 165:195.
34. + T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J. Immunol. 152:3491.
35. Gildea L. A., R. Gibbons, F. D. Finkelman, and G. S. Deepe, Jr. 2003. Overexpression of interleukin-4 in lungs of mice impairs elimination of Histoplasma capsulatum. Infect. Immun. 71:3787.
36. + T cells undergoing primary and secondary responses to infection in the same host. J. Immunol. 170:4933.
37. Schluns, K. S., and L. Lefrançois. 2003. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3:269.
38. Schluns, K. S. W. C. Kieper, S. C. Jameson, and L. Lefrançois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1:426.
39. + T cells. J. Immunol. 170:5018.
40. + T cells increases the size of the acute antiviral response and of the resulting memory T cell pool. J. Immunol. 169:4990.
41. - phenotype) and their contribution to the regulation of immnoglobulin E antibody formation. Int. Arch. Allergy Immunol. 127:198.